1350 related articles for article (PubMed ID: 18072818)
1. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.
Kidd PM
Altern Med Rev; 2007 Sep; 12(3):207-27. PubMed ID: 18072818
[TBL] [Abstract][Full Text] [Related]
2. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
3. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
[TBL] [Abstract][Full Text] [Related]
4. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations.
McNamara RK
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):223-31. PubMed ID: 19515544
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids in cellular membranes: a unified concept.
Valentine RC; Valentine DL
Prog Lipid Res; 2004 Sep; 43(5):383-402. PubMed ID: 15458813
[TBL] [Abstract][Full Text] [Related]
8. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
Gow RV; Matsudaira T; Taylor E; Rubia K; Crawford M; Ghebremeskel K; Ibrahimovic A; Vallée-Tourangeau F; Williams LM; Sumich A
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):151-6. PubMed ID: 19230637
[TBL] [Abstract][Full Text] [Related]
9. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study.
Hirayama S; Hamazaki T; Terasawa K
Eur J Clin Nutr; 2004 Mar; 58(3):467-73. PubMed ID: 14985685
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
12. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
13. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.
Sorgi PJ; Hallowell EM; Hutchins HL; Sears B
Nutr J; 2007 Jul; 6():16. PubMed ID: 17629918
[TBL] [Abstract][Full Text] [Related]
14. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why?
Das UN
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217
[TBL] [Abstract][Full Text] [Related]
15. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
16. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
[TBL] [Abstract][Full Text] [Related]
17. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
19. The effects of docosahexaenoic acid-rich fish oil on behavior, school attendance rate and malaria infection in school children--a double-blind, randomized, placebo-controlled trial in Lampung, Indonesia.
Hamazaki K; Syafruddin D; Tunru IS; Azwir MF; Asih PB; Sawazaki S; Hamazaki T
Asia Pac J Clin Nutr; 2008; 17(2):258-63. PubMed ID: 18586645
[TBL] [Abstract][Full Text] [Related]
20. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study.
Chen CT; Liu Z; Ouellet M; Calon F; Bazinet RP
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):157-63. PubMed ID: 19237271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
